5762-40-3 Usage
General Description
2,4-Dimethyl-4-nitrovaleric acid methyl ester is an organic compound with the chemical formula C7H11NO4. It is a methyl ester derivative of 2,4-dimethyl-4-nitrovaleric acid, and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 2,4-Dimethyl-4-nitrovaleric acid methyl ester is a yellow solid that is sparingly soluble in water but freely soluble in most organic solvents. It is primarily used as a building block in the production of various chemicals and is known for its potent nitroalkanes functional group.
Check Digit Verification of cas no
The CAS Registry Mumber 5762-40-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,6 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5762-40:
(6*5)+(5*7)+(4*6)+(3*2)+(2*4)+(1*0)=103
103 % 10 = 3
So 5762-40-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H15NO4/c1-6(7(10)13-4)5-8(2,3)9(11)12/h6H,5H2,1-4H3
5762-40-3Relevant articles and documents
PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
-
Paragraph 0483-0486, (2021/08/13)
The disclosure provides processes for preparing a compound of Formula (I).
METHODS OF TREATMENT FOR CYSTIC FIBROSIS
-
Paragraph 00194-00195, (2020/12/11)
This application describes methods of treating cystic fibrosis comprising administering Compound I:, a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising any of the foregoing.
METHODS OF TREATMENT FOR CYSTIC FIBROSIS
-
Paragraph 00146-00147, (2019/02/06)
Compound I of the formula (I) and/or pharmaceutically acceptable salt(s) of Compound I comprised in a pharmaceutical composition and methods of using the same to treat cystic fibrosis.